Dual modulation of vascular function by perivascular adipose tissue and its potential correlation with adiposity/lipoatrophy-related vascular dysfunction

Current Pharmaceutical Design

Volumn 13, Issue 21, 2007, Pages 2185-2192

  Gao, Yu Jing ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Adiposity; Artery; Contraction; Hypertension; Perivascular adipose tissue; Relaxation

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ANGIOTENSIN II; ATORVASTATIN; MITOGEN ACTIVATED PROTEIN KINASE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; POTASSIUM CHANNEL; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; SEROTONIN; SUPEROXIDE;

ADIPOCYTE; ADIPOSE TISSUE; BLOOD PRESSURE; BLOOD VESSEL TONE; BODY FAT; CORRELATION ANALYSIS; ENDOCRINE SYSTEM; ENZYME ACTIVATION; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; HYPERTENSION; LIPOATROPHY; NERVE STIMULATION; NONHUMAN; OBESITY; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VASCULAR DISEASE; VASOCONSTRICTION; VASODILATATION;

ADIPOSE TISSUE; ADIPOSITY; ANIMALS; HUMANS; LIPODYSTROPHY; OBESITY; REACTIVE OXYGEN SPECIES; SUPEROXIDES; VASCULAR DISEASES; VASOCONSTRICTION; VASODILATION;

EID: 34447529334     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161207781039634     Document Type: Review

References (79)

1. Guerre-Millo M. Adipose tissue hormones. J Endocrinol Invest 2002; 25: 855-61.
2. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000; 11: 327-32.
3. Momin AU, Melikian N, Shah AM, Grieve DJ, Wheatcroft SB, John L, et al. Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: Evidence for tissue specificity of leptin resistance. Eur Heart J 2006; 27: 2294-9.
4. Kimura K, Tsuda K, Baba A, Kawabe T, Boh-oka S-I, Ibata M, et al. Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin. Biochem Biophys Res Commun 2000; 273: 745-9.
5. Carlyle M, Jones OB, Kuo JJ, Hall JE. Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension 2002; 39: 496-501.
6. Soltis EE, Cassis LA. Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. Clin Exp Hypertens A 1991; A13: 277-96.
7. Lohn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM. Periadventitial fat releases a vascular relaxing factor. FASEB J 2002; 16: 1057-63.
8. Cinti S. Anatomy of the adipose organ. Eat Weight Disord 2000; 5: 132-42.
9. Cinti S. The adipose organ: morphological perspectives of adipose tissues. Proc Nutr Soc 2001; 60: 319-28.
10. Cinti S. Adipocyte differentiation and transdifferentiation: plasticity of the adipose organ. J Endocrinol Invest 2002; 25: 823-35.
11. Gollasch M, Dubrovska G. Paracrine role for periadventitial adipose tissue in the regulation of arterial tone. Trends Pharmacol Sci 2004; 25: 647-53.
12. Gao YJ, Zeng ZH, Teoh K, Sharma AM, Abouzahr L, Cybulsky I, et al. Perivascular adipose tissue modulates vascular function in the human internal thoracic artery. J Thorac Cardiovasc Surg 2005; 130: 1130-6.
13. Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Kotani K, Tokunaga K. Pathophysiology and pathogenesis of visceral fat obesity. Obes Res 1995; 3(Suppl 2): 187S-94S.
14. Anderson PJ, Chan JC, Chan YL, Tomlinson B, Young RP, Lee ZS, et al. Visceral fat and cardiovascular risk factors in Chinese NIDDM patients. Diabetes Care 1997; 20: 1854-8.
15. Hernandez-Ono A, Monter-Carreola G, Zamora-Gonzalez J, Cardoso-Saldana G, Posadas-Sanchez R, Torres-Tamayo M, et al. Association of visceral fat with coronary risk factors in a population-based sample of postmenopausal women. Int J Obes Relat Metab Disord 2002; 26: 33-9.
16. Gao YJ, Holloway AC, Zeng ZH, Lim GE, Petrik JJ, Foster WG, et al. Prenatal exposure to nicotine causes postnatal obesity and altered perivascular adipose tissue function. Obes Res 2005; 13: 687-92.
17. Engeli S, Schling P, Gorzelniak K, Boschmann M, Janke J, Ailhaud G, et al. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol 2003; 35: 807-25.
18. Chappell MC, Modrall JG, Diz DI, Ferrario CM. Novel aspects of the renal renin-angiotensin system: angiotensin-(1-7), ACE2 and blood pressure regulation. Contrib Nephrol 2004; 143: 77-89.
19. Ferreira AJ, Santos RA. Cardiovascular actions of angiotensin-(1-7). Braz J Med Biol Res 2005; 38: 499-507.
20. Oda A, Taniguchi T, Yokoyama M. Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci 2001; 47: 141-50.
21. Barillari G, Albonici L, Incerpi S, Bogetto L, Pistritto G, Volpi A, et al. Inflammatory cytokines stimulate vascular smooth muscle cells locomotion and growth by enhancing alpha5beta1 integrin expression and function. Atherosclerosis 2001; 154: 377-85.
22. Selzman CH, Shames BD, Reznikov LL, Miller SA, Meng X, Barton HA, et al. Liposomal delivery of purified inhibitory-kappaBalpha inhibits tumor necrosis factor-alpha-induced human vascular smooth muscle proliferation. Circ Res 1999; 84: 867-75.
23. Warne JP. Tumour necrosis factor alpha: a key regulator of adipose tissue mass. J Endocrinol 2003; 177: 351-5.
24. Watanabe S, Mu W, Kahn A, Jing N, Li JH, Lan HY, et al. Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells. Am J Nephrol 2004; 24: 387-92.
25. Matsumoto S, Kishida K, Shimomura I, Maeda N, Nagaretani H, Matsuda M, et al. Increased plasma HB-EGF associated with obesity and coronary artery disease. Biochem Biophys Res Commun 2002; 292: 781-6.
26. Nagata D, Takeda R, Sata M, Satonaka H, Suzuki E, Nagano T, et al. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation. Circulation 2004; 110: 444-51.
27. Barandier C, Montani JP, Yang Z. Mature adipocytes and perivascular adipose tissue stimulate vascular smooth muscle cell proliferation: effects of aging and obesity. Am J Physiol Heart Circ Physiol 2005; 289: H1807-13.
28. Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002; 105: 2893-8.
29. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002; 277: 37487-91.
30. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002; 106: 2767-70.
31. Bahia L, Aguiar LG, Villela N, Bottino D, Godoy-Matos AF, Geloneze B, et al. Adiponectin is associated with improvement of endothelial function after rosiglitazone treatment in non-diabetic individuals with metabolic syndrome. Atherosclerosis May 05, 2007; [Epub ahead of print].
32. Hopkins TA, Ouchi N, Shibata R, Walsh K. Adiponectin actions in the cardiovascular system. Cardiovasc Res 2007; 74: 11-8.
33. Langille BL, O'Donnell F. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science 1986; 231: 405-7.
34. Peng L, Bhatia N, Parker AC, Zhu Y, Fay WP. Endogenous vitronectin and plasminogen activator inhibitor-1 promote neointima formation in murine carotid arteries. Arterioscler Thromb Vasc Biol 2002; 22: 934-9.
35. de Waard V, Arkenbout EK, Carmeliet P, Lindner V, Pannekoek H. Plasminogen activator inhibitor 1 and vitronectin protect against stenosis in a murine carotid artery ligation model. Arterioscler Thromb Vasc Biol 2002; 22: 1978-83.
36. Xiaoli M, Wenying H, Mingpeng S. Effects and mechanism of tissue-type plasminogen activator and plasminogen activator inhibitor on vascular smooth muscle cell proliferation. Int J Cardiol 1998; 66(Suppl 1): S57-64.
37. Ratajska A, Campbell SE, Cleutjens JP, Weber KT. Angiotensin II and structural remodeling of coronary vessels in rats. J Lab Clin Med 1994; 124: 408-15.
38. Shen WL, Gao PJ, Che ZQ, Ji KD, Yin M, Yan C, et al. NAD(P)H oxidase-derived reactive oxygen species regulate angiotensin-II induced adventitial fibroblast phenotypic differentiation. Biochem Biophys Res Commun 2006; 339: 337-43.
39. Ardanaz N, Pagano PJ. Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction. Exp Biol Med (Maywood) 2006; 231: 237-51.
40. Davidson CA, Kaminski PM, Wolin MS. Endogenous peroxynitrite generation causes a subsequent suppression of coronary arterial contraction to serotonin. Nitric Oxide 1997; 1: 244-53.
41. Miller FJ Jr, Gutterman DD, Rios CD, Heistad DD, Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 1998; 82: 1298-305.
42. Rosen GM, Freeman BA. Detection of superoxide generated by endothelial cells. Proc Natl Acad Sci USA 1984; 81: 7269-73.
43. Wang HD, Pagano PJ, Du Y, Cayatte AJ, Quinn MT, Brecher P, et al. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res 1998; 82: 810-8.
44. Gao YJ, Takemori K, Su LY, An WS, Lu C, Sharma AM, et al. Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion. Cardiovasc Res 2006; 71: 363-73.
45. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-61.
46. Ookawara T, Imazeki N, Matsubara O, Kizaki T, Oh-Ishi S, Nakao C, et al. Tissue distribution of immunoreactive mouse extracellular superoxide dismutase. Am J Physiol 1998; 275: C840-7.
47. 2- in vascular smooth muscle cells. Circ Res 1995; 77: 29-36.
48. Rao GN, Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 1992; 70: 593-9.
49. Rao GN, Lassegue B, Griendling KK, Alexander RW. Hydrogen peroxide stimulates transcription of c-jun in vascular smooth muscle cells: role of arachidonic acid. Oncogene 1993; 8: 2759-64.
50. Gao YJ, Hirota S, Zhang D, Janssen LJ, Lee RMKW. Mechanisms of hydrogen peroxide-induced biphasic response in rat mesenteric artery. Br J Pharmacol 2003; 138: 1085-92.
51. Ullrich V, Bachschmid M. Superoxide as a messenger of endothelial function. Biochem Biophys Res Commun 2000; 278: 1-8.
52. Torrecillas G, Boyano-Adanez MDC, Medina J, Parra T, Griera M, Lopez-Ongil S, et al. The role of hydrogen peroxide in the contraction response to angiotensin II. Mol Pharmacol 2001; 59: 104-12.
53. Frank GD, Eguchi S, Yamakawa T, Tanaka SI, Inagami T, Motley ED. Involvement of reactive oxygen species in the activation of tyrosine kinase and extracellular signal-regulated kinase by angiotensin II. Endocrinology 2000; 141: 3120-6.
54. 2 signals 5-HT-induced ERK MAP kinase activation and mitogenesis of smooth myscle cells. Am J Physiol 2001; 281: L646-52.
55. Miura H, Bosnjak JJ, Ning G, Saito T, Miura M, Gutterman DD. Role of hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circ Res 2003; 92: e31-e40.
56. Ca channel activity. Am J Physiol 1998; 275: H1283-9.
57. Dubrovska G, Verlohren S, Luft FC, Gollasch M. Mechanisms of ADRF release from rat aortic adventitial adipose tissue. Am J Physiol Heart Circ Physiol 2004; 286: H1107-13.
58. Takemori K, Gao YJ, Ding l, Lu C, Su LY, An WS, et al. Elevated blood pressure in transgenic lipoatrophic mice and altered vascular function. Hypertension 2007; 49: 365-72.
59. Verlohren S, Dubrovska G, Tsang SY, Essin K, Luft FC, Huang Y, et al. Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries. Hypertension 2004; 44: 271-6.
60. Galvez B, de Castro J, Herold D, Dubrovska G, Arribas S, Gonzalez MC, et al. Perivascular Adipose Tissue and Mesenteric Vascular Function in Spontaneously Hypertensive Rats. Arterioscler Thromb Vasc Biol 2006; 26: 1297-302.
61. Kawazoe T, Kosaka H, Yoneyama H, Hata Y. Acute production of vascular superoxide by angiotensin II but not by catecholamines. J Hypertens 2000; 18: 179-85.
62. 1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neuro-transmission in the rat mesenteric artery. J Cardiovasc Pharmacol 2001; 38: 141-8.
63. Ahren B, Havel PJ. Leptin increases circulating glucose, insulin and glucagon via sympathetic neural activation in fasted mice. Int J Obes Relat Metab Disord 1999; 23: 660-5.
64. Hasdan G, Benchetrit S, Rashid G, Green J, Bernheim J, Rathaus M. Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide. Kidney Int 2002; 61: 586-90.
65. Abate N. Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications. J Diabetes Complications 2000; 14: 154-74.
66. Alexander JK. Obesity and coronary heart disease. Am J Med Sci 2001; 321: 215-24.
67. Correia ML, Haynes WG. Obesity-related hypertension: is there a role for selective leptin resistance? Curr Hypertens Rep 2004; 6: 230-5.
68. Eikelis N, Esler M. The neurobiology of human obesity. Exp Physiol 2005; 90: 673-82.
69. Arioglu E, Rother KI, Reitman ML, Premkumar A, Taylor SI. Lipoatrophy syndromes: when 'too little fat' is a clinical problem. Pediatr Diabetes 2000; 1: 155-68.
70. Reitman ML, Arioglu E, Gavrilova O, Taylor SI. Lipoatrophy revisited. Trends Endocrinol Metab 2000; 11: 410-6.
71. Moitra J, Mason MM, Olive M, Krylov D, Gavrilova O, Marcus-Samuels B, et al. Life without white fat: a transgenic mouse. Genes Dev 1998; 12: 3168-81.
72. Gavrilova O, Marcus-Samuels B, Graham D, Kim JK, Shulman GI, Castle AL, et al. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 2000; 105: 271-8.
73. Zhang ZH, Zeng ZH, Lee RMKW, Gao YJ, Luo BH, He WK, et al. Functional changes of perivascular adipose tissue in hypertensive rats and the effects of statins therapy. Zhonghua Bing Li Sheng Li Xue Za Zhi 2006; 22: 1680-3.
74. Nisoli E, Cardile A, Bulbarelli A, Tedesco L, Bracale R, Cozzi V, et al. White adipocytes are less prone to apoptotic stimuli than brown adipocytes in rodent. Cell Death Differ 2006; 13: 2154-6.
75. Kraus D, Fasshauer M, Ott V, Meier B, Jost M, Klein HH, et al. Leptin secretion and negative autocrine crosstalk with insulin in brown adipocytes. J Endocrinol 2002; 175: 185-91.
76. Crandall DL, Hausman GJ, Kral JG. A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 1997; 4: 211-32.
77. Disanto ME. Contractile mechanisms in diabetes-related erectile dysfunction. Curr Pharm Des 2005; 11(31): 3995-4010.
78. Rodi D, Couture R, Ongali B, Simonato M. Targeting kinin receptors for the treatment of neurological diseases. Curr Pharm Des 2005; 11(10): 1313-26.
79. Seftel AD. Phosphodiesterase type 5 inhibitors: molecular pharmacology and interactions with other phosphodiesterases. Curr Pharm Des 2005; 11(31): 4047-58.